Policy & Ethics

The Centers for Disease Control and Prevention (CDC) recently reported that overdose deaths during the 12-month period ending in December 2025 declined by 13.9

 

For many years, the medical establishment has argued, and in my view correctly, that addiction is a legitimate neurobiological condition that may often require long-term pharmacologic treatment, including with an opioid such as buprenorphine or me

In complex systems, intermediaries can “grease the wheels” by lowering transaction costs, streamlining logistics, and bridging information gaps.

In one of the most consequential institutional changes at the EPA in decades, Deputy Administrator David Fotouhi announced in an internal memo that the EPA will no longer use the Integrated Risk Information System (IRIS) program to develop c

There is a tale, often retold in modern healthcare discourse: the tension between not only two competing industries, but, more importantly, two different ideologies concerning the nature of the scientific method and its philosophical foundat

On November 24, 2024, before taking office to start his second term, then-President-elect Trump nominated Dr. Janette Neshiewat, a Fox News medical commentator, to become the next Surgeon General of the United States.

ACSH is pleased to announce that Dr. Lynn Webster has joined our Board of Scientific Advisors. A nationally recognized expert in pain medicine and addiction, he brings deep clinical and research expertise to the organization.

Join Cameron English and Dr. Chuck Dinerstein on the Science Dispatch podcast as they discuss: